Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: A role of acidosis-induced c-Src activation

Hypertension Research

Volumn 32, Issue 3, 2009, Pages 182-187

  Echizen, Takashi ^a   Osanai, Tomohiro ^a   Ashitate, Toshihiro ^a   Yokoyama, Hiroaki ^a   Shibutani, Shuji ^a   Tanaka, Makoto ^a   Tomita, Hirofumi ^a   Magota, Koji ^b   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EFRAPEPTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROSTACYCLIN COUPLING FACTOR 6; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL PH; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; UPREGULATION; VASCULAR ENDOTHELIUM;

ACIDOSIS; ANIMALS; ANOXIA; BIOTRANSFORMATION; BLOTTING, WESTERN; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MICE; MICE, TRANSGENIC; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 68249149372     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2008.24     Document Type: Article

References (29)

1. Morbidelli L, Chang CH, Douglus JG, Glanger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270: H411-H415.
2. Han He, Venema VJ, Gu X, Venema RC, Mario MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 1999; 274: 25130-25135.
3. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/ Fit-1): A dual regulator for angiogenesis. Angiogenesis 2006; 9 225-230.
4. Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Weich HA. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 2000; 80: 443-454.
5. Richard DE, Berra E, Pouysségur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1a in vascular smooth muscle cells. J Biol Chem 2000; 275; 26765-26771.
6. Page EL, Robitaille GA, Pouyssegur J, Richard DE. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 2002; 277: 48403-48409.
7. Osanai T, Tanaka M, Kamada T, Nakano T, Takahashi K, Okada S, Sirato K, Magota K, Kodama S, Okumura K. Mitochondrial coupling factor 6 as a novel endogenous vasoconstrictor. J Clin Invest 2001; 108: 1023-1030.
8. Osanai T, Kamada T, Fujiwara N, Katoh T, Takahashi K, Kimura M, Satoh K, Magota K, Kodama S, Tanaka T, Okumura K. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem 1998; 273: 31778-31783.
9. Tanaka M, Osanai T, Murakami R, Sasaki S, Tomita H, Maeda N, Satoh K, Magota K, Okumura K. Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: Enhanced release of asymmetric dimethylarginine. J Hypertens 2006; 24: 489-497.
10. Moser TL, Stack MS, Schnaper HW, Asplin I, Enghild JJ, Højrup P, Everitt L, Hubchak S, Pizzo SV. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96: 2811-2816.
11. o ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001; 98: 6656-6661.
12. Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, Tomita H, Maeda N, Okumura K. Intracellular signaling for vasoconstrictor coupling factor 6: Novel function of β-subunit of ATP synthase as receptor. Hypertension 2005; 46: 1140-1146.
13. Matsumoto H, Rogi T, Yamashiro K, Takio K, Kodama S, Tsuruoka N, Hattori A, Mizutani S, Tsujimoto M. Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur J Biochem 2000; 267: 46-52.
14. Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005; 26 210-217.
15. Nevo O, Soleymanlou N, Caniggia I, Wu Y, Xu J, Kingdom J, Many A, Zamudio S. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol 2006; 291: R1085-R1093.
16. Itoh H, Nasu K, Matsumoto H, Kawano Y, Yoshimatsu J, Narahara H. Hypoxia regulates vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts. Fertil Steril 2006; 85: 1097-1102.
17. Kumagai A, Osanai T, Katoh C, Tanaka M, Tomita H, Morimoto T, Murakami R, Magota K, Okumura K. Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule. Atherosclerosis 2008; 200: 45-50.
18. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 1999; 13: 537-545.
19. Ward JPT, Knock GA, Snetkov VA, Aaronson PI. Protein kinases in vascular smooth muscle tone-role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction. Pharmacol Ther 2004; 104: 207-231.
20. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007; 115: 1789-1797.
21. Schnabel R, Lubos M, Messow C, Sinnig C, Rupprecht H-J, Espinola-Klein C, Bicker C, Lackner KJ, Peetz D, Tiret L, Blankenberg S. Soluble Flt-1 as an early diagnostic marker in acute coronary syndromes: Results from the AtheroGene study. Eur Heart J 2008; 29: 649-657.
22. Sugimoto H, Hamano Y, Kalluri R, Charytan D, Cosgrove D, Kieran M, Sudhakar A. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278: 12605-12608.
23. Maynard SE, Min JY, Sukhatme VP, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
24. Osanai T, Sasaki S, Kamada T, Fujiwara N, Nakano T, Tomita H, Matsunaga T, Magota K, Okumura K. Circulating coupling factor 6 in human hypertension: Role of reactive oxygen species. J Hypertens 2003; 21: 2323-2328.
25. Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, Osawa H, Yamabe H, Murakami S, Magota K, Okumura K. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 2003; 64: 2291-2297.
26. Li XL, Xing QC, Dong B, Gao YY, Xing SS, Pang YZ, Jiang HF, Tang CS. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol 2007; 117: 411-412.
27. Osanai T, Okada S, Sirato K, Nakano T, Saitoh M, Magota K, Okumura K. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and released by shear stress. Circulation 2001; 104: 3132-3136.
28. Sasaki S, Osanai T, Tomita H, Matsunaga T, Magota K, Okumura K. Tumor necrosis factor a as an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res 2004; 62: 578-586.
29. 2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res 2005; 67: 134-141.